96420-5

LOINC 2.82

Daratumumab [Presence] in Serum by Immunofixation

Daratumumab Ser Ql IFE

Definition

  • Daratumumab is a monoclonal antibody used to treat multiple myeloma, which is, itself, a disease that results in antibody overproduction, shown as M protein band in immunoelectrophoresis. Daratumumab, the treatment, can show up as part of the M spike and interfere with the assay for the M-protein in multiple myeloma. An antibody against Daratumumab can be added to the assay, which shifts the Daratumumab band, allowing the Daratumumab band to be distinguished from the M-protein band and reported separately.

Component

  • Daratumumab

Specimen / system

  • Ser

Class

  • CHEM

Property

  • PrThr

Scale

  • Ord

Method

  • Immunofixation

Related names

  • Chemistry; DARZALEX; IFE; Ifix; Immunofixation electrophoresis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR

Index terms

  • Chemistry
  • DARZALEX
  • IFE
  • Ifix
  • Immunofixation electrophoresis
  • Ordinal
  • Point in time
  • PR
  • QL
  • Qual
  • Qualitative
  • Random
  • Screen
  • Serum
  • SR